NCT07250542: A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 30 planned
- Started
- 5 Jul 2024
- Primary completion
- 30 Dec 2025
- Arms
- The group treated with farsulide hydrochloride combined with immunotherapy
- Results
- None posted
- 5 Jul 2024: Trial started
- 26 Nov 2025: Trial registered